Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.58 | -1.06071689832 | 54.68 | 57.46 | 52.14 | 729910 | 53.32253194 | CS |
4 | -12.23 | -18.438112468 | 66.33 | 68.49 | 52.14 | 888483 | 58.97691612 | CS |
12 | 7.15 | 15.2289669862 | 46.95 | 71.71 | 40.0183 | 1018686 | 56.0400776 | CS |
26 | 14.98 | 38.2924335378 | 39.12 | 71.71 | 34.5125 | 765137 | 51.21251262 | CS |
52 | 43.13 | 393.163172288 | 10.97 | 71.71 | 7.79 | 779453 | 48.34776242 | CS |
156 | 34 | 169.154228856 | 20.1 | 71.71 | 5.65 | 323604 | 41.41856455 | CS |
260 | 20.1 | 59.1176470588 | 34 | 71.71 | 5.65 | 302538 | 39.81469933 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.